Share on LinkedInShare on LinkedIn

ARTICLE · 31 MARCH 2025

"Navigating AI's Impact On Life Sciences And Patent Law"

Marshall Gerstein Partner Noah Tilton contributed a column to Life Science Leader discussing artificial intelligence's impact on the life science industry. With all the benefits of this emerging technology – such as drug discovery, clinical trials, and regulatory compliance – also come challenges for protecting intellectual property.

United StatesIntellectual Property

Marshall Gerstein Partner Noah Tilton contributed a column to Life Science Leader discussing artificial intelligence's impact on the life science industry. With all the benefits of this emerging technology – such as drug discovery, clinical trials, and regulatory compliance – also come challenges for protecting intellectual property.

"AI implementation in life sciences raises various patent law considerations, including patent subject matter eligibility, novelty/obviousness, and sufficiency of disclosure," Noah wrote in describing the various obstacles innovators may face in protecting their IP.

Read Noah's solutions in his column in Life Science Leader.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from